How many boxes of erdafitinib should be taken per month? Recommended dosage and medication period

Erdafitinib is used to treat locally advanced or metastatic urothelial cancer harboring FGFR gene mutations and is usually administered orally. The recommended starting dose is 8mg (2 tablets 4mg) once a day, depending on the Adjust to 9mg (3 tablets3mg) once a day according to the patient's blood phosphorus level. Since the common specification of a box of erdafitinib is 4mg*56 tablets, based on the recommended dosage of 8mg and taking 2 tablets per day, one box can be taken for approximately 28 days. If the dose is adjusted to 9 mg once daily, the period of use per box may be shortened.

The medication cycle is usually 28 consecutive days. The doctor will evaluate whether to continue taking it based on the patient's tolerance and efficacy. For some patients, if blood phosphorus levels remain within a safe range during treatment and no serious adverse reactions occur, doctors may recommend increasing the dose to 9mg to optimize the therapeutic effect. In this case, the patient may need to purchase an additional box of medication each month to ensure adequate dosage.

Because the dose adjustment of erdafitinib involves monitoring the patient's blood phosphorus levels, blood indicators need to be checked regularly during the medication. Usually, the initial serum phosphorus monitoring is performed on the 14th to 21st days of treatment, and whether the dose needs to be adjusted is determined based on the test results. In addition, patients need to pay close attention to changes in vision, skin reactions, and other potential side effects during treatment, such as oral ulcers, fatigue, or hyperphosphatemia. If obvious discomfort occurs, seek medical attention immediately, and the doctor may adjust the dose or suspend treatment.

In general, the specific medication cycle and monthly dosage of erdafitinib will vary according to the individualized treatment plan. For most patients, a starting dose (8mg) would be 1box (56 tablets); and if adjusted to 9mg, it may require 1.5 boxes to 2 per monthbox. It is recommended that patients fully communicate with their doctors before use and conduct regular review to ensure the safety and effectiveness of the treatment.

Reference link:https://www.balversa.com/